News
Canadian cannabis and beverage alcohol company Tilray Brands is gearing up for potential marijuana reform in the U.S. by announcing plans to raise up to $250 million through an at-the-market…
The Drug Enforcement Administration (DEA) published proposed rules in the U.S. Federal Register yesterday to reschedule marijuana from Schedule I to Schedule III of the Controlled Substances Act. This represents…
The Office of Cannabis Management’s Chief Equity Officer, Damian Fagon, finds himself under scrutiny as the New York Inspector General’s Office investigates allegations of retaliation and selective enforcement. Fagon has…
Last week, the Biden administration proposed new rules that would reclassify marijuana from Schedule I to Schedule III, removing it from the list reserved for the most dangerous drugs —…
The farm bill has ignited a contentious battle between hemp and marijuana, as policymakers grapple with the regulation of intoxicating products derived from legal hemp. This clash of interests has…
For half a century, critics have argued that cannabis does not belong in Schedule I of the Controlled Substances Act, a category supposedly reserved for drugs with a high potential…
A federal judge has approved a request from marijuana companies to allow public access to a crucial hearing this week in a significant case concerning shielding in-state cannabis activity from…
As Delaware gears up for the launch of its adult-use marijuana market, lawmakers have introduced a groundbreaking bill aimed at expediting the process. Creating Opportunities for Existing Medical Cannabis Businesses…
Louisiana House Votes Down Measure to Establish Cannabis Regulations Ahead of Adult-Use Legalization
House lawmakers in Louisiana rejected legislation on Monday that would have established a regulatory framework for legalizing adult-use marijuana in the state. The Proposal and Its Intent Representative Candace Newell…
The CEO of a major cannabis company, Kim Rivers of Trulieve, has expressed confidence that Florida Governor Ron DeSantis (R) will respect the will of the people and implement a…
Dr. Rahul Gupta, the director of the Office of National Drug Control Policy, recently discussed the Biden administration’s efforts to reclassify marijuana from a Schedule 1 to a Schedule 3…
Federal Rescheduling: Influential Groups Outline Strategies
The Biden administration has formally initiated the process to reschedule marijuana at the federal level, sparking anticipation from advocates and opponents of cannabis reform alike. The proposed rule, which seeks…
Read More about Federal Rescheduling: Influential Groups Outline Strategies